Michal Šmída

931 total citations
23 papers, 626 citations indexed

About

Michal Šmída is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Michal Šmída has authored 23 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Michal Šmída's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Michal Šmída is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Michal Šmída collaborates with scholars based in Czechia, Germany and Austria. Michal Šmída's co-authors include Burkhart Schraven, Jonathan A. Lindquist, Jürgen Kraus, Christine Börner, Volker Höllt, Sebastian Nijman, Veronika Mančíková, Iris Z. Uras, Roland Hartig and Claudia Kerzendorfer and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Michal Šmída

22 papers receiving 617 citations

Peers

Michal Šmída
Cindy Fishman United States
Michal Šmída
Citations per year, relative to Michal Šmída Michal Šmída (= 1×) peers Cindy Fishman

Countries citing papers authored by Michal Šmída

Since Specialization
Citations

This map shows the geographic impact of Michal Šmída's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Šmída with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Šmída more than expected).

Fields of papers citing papers by Michal Šmída

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Šmída. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Šmída. The network helps show where Michal Šmída may publish in the future.

Co-authorship network of co-authors of Michal Šmída

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Šmída. A scholar is included among the top collaborators of Michal Šmída based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Šmída. Michal Šmída is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozubík, Kateřina Staňo, Magdalena Skalnı́ková, Tomáš Loja, et al.. (2024). A novel thrombocytopenia‐4‐causing CYCS gene variant decreases caspase activity: Three‐generation study. British Journal of Haematology. 205(6). 2450–2458. 5 indexed citations
2.
Novotný, Jan, Petra Ovesná, Tereza Suchánková, et al.. (2024). Thieno[3,2‐b]pyridine: Attractive scaffold for highly selective inhibitors of underexplored protein kinases with variable binding mode. Angewandte Chemie International Edition. 64(1). e202412786–e202412786.
3.
Skalnı́ková, Magdalena, Kateřina Staňo Kozubík, Lenka Radová, et al.. (2022). A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome. International Journal of Molecular Sciences. 23(2). 885–885. 3 indexed citations
4.
Dave, Zankruti, Pavlína Janovská, Pavel Krejčı́, et al.. (2022). Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells. Frontiers in Cell and Developmental Biology. 10. 838871–838871. 7 indexed citations
5.
Loja, Tomáš, et al.. (2021). Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro. Journal for ImmunoTherapy of Cancer. 9(8). e002352–e002352. 20 indexed citations
6.
Mančíková, Veronika & Michal Šmída. (2021). Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 22(11). 5536–5536. 24 indexed citations
7.
Janovská, Pavlína, Aleksander Ślusarczyk, Jan Oppelt, et al.. (2020). CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells. PLoS ONE. 15(3). e0229170–e0229170. 13 indexed citations
8.
Mančíková, Veronika, Jan Verner, Tomáš Loja, et al.. (2020). Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia. Journal for ImmunoTherapy of Cancer. 8(1). e000471–e000471. 11 indexed citations
10.
Šmída, Michal, Ferran Fece de la Cruz, Claudia Kerzendorfer, et al.. (2016). MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated. Nature Communications. 7(1). 13701–13701. 33 indexed citations
11.
Doubek, Michael & Michal Šmída. (2015). Treatment of chronic lymphocytic leukemia with monoclonal antibodies, where are we heading?. Expert Review of Hematology. 8(6). 743–764. 2 indexed citations
12.
Šmída, Michal. (2015). Chimeric Antigen Receptor T-cells – Gene Therapy of the Future for Malignant Diseases?. Klinicka onkologie. 28(Suppl 4). 4S44–4S47. 2 indexed citations
13.
Šmída, Michal, Holger Lingel, Luca Simeoni, et al.. (2013). PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells. Cell Communication and Signaling. 11(1). 28–28. 9 indexed citations
14.
Šmída, Michal & Sebastian Nijman. (2012). Functional drug–gene interactions in lung cancer. Expert Review of Molecular Diagnostics. 12(3). 291–302. 7 indexed citations
15.
Muellner, Markus K., Iris Z. Uras, Bianca V. Gapp, et al.. (2011). A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nature Chemical Biology. 7(11). 787–793. 134 indexed citations
16.
Busse, Mandy, Michal Šmída, Utz‐Uwe Haus, et al.. (2011). Integrating Signals from the T-Cell Receptor and the Interleukin-2 Receptor. PLoS Computational Biology. 7(8). e1002121–e1002121. 21 indexed citations
17.
Börner, Christine, Michal Šmída, Volker Höllt, Burkhart Schraven, & Jürgen Kraus. (2009). Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling. Journal of Biological Chemistry. 284(51). 35450–35460. 87 indexed citations
18.
Simeoni, Luca, et al.. (2008). Control of lymphocyte development and activation by negative regulatory transmembrane adapter proteins. Immunological Reviews. 224(1). 215–228. 25 indexed citations
19.
Filby, Andrew, Benedict Seddon, Robert J. Salmond, et al.. (2007). Fyn Regulates the Duration of TCR Engagement Needed for Commitment to Effector Function. The Journal of Immunology. 179(7). 4635–4644. 57 indexed citations
20.
Posevitz‐Fejfár, Anita, Michal Šmída, Stefanie Kliche, et al.. (2007). A displaced PAG enhances proximal signaling and SDF‐1‐induced T cell migration. European Journal of Immunology. 38(1). 250–259. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026